Research and Markets: Drug Eluting Stent Market in China: It is Forecast that the Market is set to Grow at a CAGR of 10.70% Over the Period 2014-2019

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/vktlfh/drug_eluting) has announced the addition of the "Drug Eluting Stent Market in China - Industry Research Report 2015-2019" report to their offering.

There is a growing demand for invasive procedures among the elderly population with cardiovascular diseases worldwide, which is propelling the growth of the drug-eluting stent market in China. Also, cost efficiencies offered by minimally invasive methods are likely to increase the demand for the procedures shortly. These procedures are performed through small incisions in the body, and can be used to treat plaque blockages in the arteries of the heart and other vessel walls of peripheral organs such as kidneys and brain.

According to the report, increased workload, physical inactivity, and unhealthy diet lead to high blood glucose, blood pressure, and accumulation of lipids that cause hypertension, obesity, abnormal cholesterol, and diabetic problems in individuals. These factors result in cardiac disorders, which is also prevalent among the elderly aged 65 and above. In the recent years, incidences of CVDs such as stroke, myocardial infarction, and CHDs have increased.

This report covers the present and future scenario of the drug eluting stent market in China for the period 2015-2019. To calculate the market size, the analyst uses revenue generated from the sales of drug eluting stents.

Key vendors:

  • Abbott Vascular
  • Lepu Medical
  • Medtronic
  • MicroPort Scientific
  • Shandong JW Medical Systems
  • Other prominent vendors
  • Biosensors International
  • Boston Scientific
  • Cook Medical
  • Opto Circuit
  • QualiMed
  • Sinomed
  • Terumo Medical

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Stents: An overview

PART 06: Market landscape

PART 07: Healthcare reform in China

PART 08: Opportunities for global and local vendors

PART 09: Market drivers

PART 10: Impact of drivers

PART 11: Market challenges

PART 12: Impact of drivers and challenges

PART 13: Market trends

PART 14: Vendor landscape

PART 15: Key vendor analysis

PART 16: Appendix

PART 17: About the Author

For more information visit http://www.researchandmarkets.com/research/vktlfh/drug_eluting

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Stents

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Stents